» Articles » PMID: 32374903

SARS-CoV-2 Viral Spike G614 Mutation Exhibits Higher Case Fatality Rate

Overview
Publisher Wiley
Specialty General Medicine
Date 2020 May 7
PMID 32374903
Citations 184
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The COVID-19 pandemic is caused by infection with the SARS-CoV-2 virus. The major mutation detected to date in the SARS-CoV-2 viral envelope spike protein, which is responsible for virus attachment to the host and is also the main target for host antibodies, is a mutation of an aspartate (D) at position 614 found frequently in Chinese strains to a glycine (G). We sought to infer health impact of this mutation.

Result: Increased case fatality rate correlated strongly with the proportion of viruses bearing G614 on a country by country basis. The amino acid at position 614 occurs at an internal protein interface of the viral spike, and the presence of G at this position was calculated to destabilise a specific conformation of the viral spike, within which the key host receptor binding site is more accessible.

Conclusion: These results imply that G614 is a more pathogenic strain of SARS-CoV-2, which may influence vaccine design. The prevalence of this form of the virus should also be included in epidemiologic models predicting the COVID-19 health burden and fatality over time in specific regions. Physicians should be aware of this characteristic of the virus to anticipate the clinical course of infection.

Citing Articles

Evaluation of Genomic Surveillance of SARS-CoV-2 Virus Isolates and Comparison of Mutational Spectrum of Variants in Bangladesh.

Sultana A, Banu L, Hossain M, Azmin N, Nila N, Sinha S Viruses. 2025; 17(2).

PMID: 40006937 PMC: 11860708. DOI: 10.3390/v17020182.


The COVID-19 Vaccine in Clinical Trials: Where Are We Now?.

Jiang H, Li J, Zhang P, Huo X, Zhu F Infect Dis Immun. 2024; 1(1):43-51.

PMID: 38630107 PMC: 8057314. DOI: 10.1097/ID9.0000000000000003.


The seasonal behaviour of COVID-19 and its galectin-like culprit of the viral spike.

Caetano-Anolles K, Hernandez N, Mughal F, Tomaszewski T, Caetano-Anolles G Methods Microbiol. 2024; 50:27-81.

PMID: 38620818 PMC: 8590929. DOI: 10.1016/bs.mim.2021.10.002.


SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression.

Hussein H, Thabet A, Wardany A, El-Adly A, Ali M, Hassan M Virol J. 2024; 21(1):75.

PMID: 38539202 PMC: 10967059. DOI: 10.1186/s12985-024-02342-w.


Unraveling the genetic variations underlying virulence disparities among SARS-CoV-2 strains across global regions: insights from Pakistan.

Jabeen M, Shoukat S, Shireen H, Bao Y, Khan A, Abbasi A Virol J. 2024; 21(1):55.

PMID: 38449001 PMC: 10916261. DOI: 10.1186/s12985-024-02328-8.


References
1.
Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

2.
Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

3.
Xue M, Wakamoto T, Kejlberg C, Yoshimura Y, Nielsen T, Risor M . How internal cavities destabilize a protein. Proc Natl Acad Sci U S A. 2019; 116(42):21031-21036. PMC: 6800337. DOI: 10.1073/pnas.1911181116. View

4.
Yuan M, Wu N, Zhu X, Lee C, So R, Lv H . A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020; 368(6491):630-633. PMC: 7164391. DOI: 10.1126/science.abb7269. View

5.
Becerra-Flores M, Cardozo T . SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020; 74(8):e13525. PMC: 7267315. DOI: 10.1111/ijcp.13525. View